Company Announcements

Total Voting Rights

Source: RNS
RNS Number : 0806J
Hammerson PLC
18 December 2020
 

THIS ANNOUNCEMENT (AND THE INFORMATION CONTAINED HEREIN) IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM  ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

FOR IMMEDIATE RELEASE

 

Hammerson plc (the "Company")

Voting Rights and Capital

18 December 2020

 

 

The Company announces that 225,830,124 New Shares have today been issued and admitted to trading on the London Stock Exchange and the Johannesburg Stock Exchange to satisfy the number of valid elections received to participate in the Enhanced Scrip Dividend Alternative.

 

In compliance with the Disclosure Guidance and Transparency Rules, the Company announces that its total issued share capital as at 18 December 2020 comprises 4,057,298,174 ordinary shares of 5 pence each with one voting right per share. There are no shares held in treasury.

 

The total number of voting rights in Hammerson plc is therefore 4,057,298,174. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

Unless otherwise stated, capitalised terms in this announcement shall have the meanings given to them in the Circular dated 11 November 2020 in connection with the proposed Interim 2020 Dividend and Enhanced Scrip Dividend Alternative which can be found at: https://www.hammerson.com/investors/shareholder-information/general-meeting

 

For further information contact:

 

Richard Crowle

Assistant Company Secretary

+44 (0) 20 7887 1000

 

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRKKOBNOBDDBBD